tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eliana Merle, 167 are a BUY (80.68%), 40 are a HOLD (19.32%).
Analyst Eliana Merle, currently employed at BARCLAYS, carries an average stock price target met ratio of 47.52% that have a potential upside of 43.25% achieved within 206 days. Previously, Eliana Merle worked at UBS.
Eliana Merle’s has documented 402 price targets and ratings displayed on 41 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on QURE, Uniqure NV at 23-Mar-2026.
Analyst best performing recommendations are on RAPT (RAPT THERAPEUTICS).
The best stock recommendation documented was for RAPT (RAPT THERAPEUTICS) at 5/22/2025. The price target of $8 was fulfilled within 1 day with a profit of $1.14 (16.62%) receiving and performance score of 166.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-Mar-2020
$31
$13.79 (80.13%)
$35
13 days ago
(18-Mar-2026)
2/20 (10%)
$13.11 (73.28%)
570
Hold Since 02-Nov-2023
$20
$3.03 (17.86%)
$19
26 days ago
(05-Mar-2026)
10/18 (55.56%)
$-0.15 (-0.74%)
41
Buy Since 04-Dec-2017
$44
$27.03 (159.28%)
$45
1 months 6 days ago
(25-Feb-2026)
20/28 (71.43%)
$22.58 (105.42%)
216
Hold Since 10-Sep-2021
$18
$1.03 (6.07%)
$22
1 months 6 days ago
(25-Feb-2026)
18/19 (94.74%)
$-3.42 (-15.97%)
110
Buy Since 19-Jul-2022
$48
$31.03 (182.85%)
$45
1 months 6 days ago
(25-Feb-2026)
3/28 (10.71%)
$26.58 (124.09%)
108
Which stock is Eliana Merle is most bullish on?
Which stock is Eliana Merle is most reserved on?
What Year was the first public recommendation made by Eliana Merle?
